Clinical trial
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
NCT00272558 · Rigshospitalet, Denmark, Other · Completed
Key facts
| NCT number | NCT00272558 |
|---|---|
| Title | Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma |
| Official title | Phase II Study of Carboplatin and Vinorelbine i.v. (Day 1) and Orally (Day 8) for Malignant Pleural Mesothelioma |
| Lead sponsor | Rigshospitalet, Denmark, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Pleural Mesothelioma |
| Intervention type | Drug |
| Interventions | Carboplatin and Vinorelbine |
| Enrollment | 40 |
| Start date | Sep 1, 2004 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jan 6, 2006 |
| Last update posted | Sep 18, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: